FRIESON RON (CIK 1890219) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-22). Recent activity: Buy AKBA (35,700 shares), Buy AKBA (35,700 shares), Buy AKBA (20,100 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Akebia Therapeutics, Inc. (AKBA) | Director | Buy | 35,700 | $0 |
| 2025-06-11 | Akebia Therapeutics, Inc. (AKBA) | Director | Buy | 35,700 | $0 |
| 2025-01-22 | Akebia Therapeutics, Inc. (AKBA) | Director | Buy | 20,100 | $9,045 |
Source: SEC Form 4 filings · as of 2026-06-22